1.
Gordon K, Warren R, Gottlieb A, Blauvelt A, Tha├ži D, Poulin Y, Boehnlein M, Brock F, Arendt C, Reich K. Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2, and CIMPACT). J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.18];4(6):s81. Available from: https://jofskin.org/index.php/skin/article/view/1114